| Identification | Back Directory | [Name]
1,6-Naphthyridine-6(5H)-carboxamide, N-[2-(4-fluorophenoxy)-5-pyrimidinyl]-5-(4-fluorophenyl)-7,8-dihydro-, (5S)- | [CAS]
2471967-92-5 | [Synonyms]
BAY-899
1,6-Naphthyridine-6(5H)-carboxamide, N-[2-(4-fluorophenoxy)-5-pyrimidinyl]-5-(4-fluorophenyl)-7,8-dihydro-, (5S)- | [Molecular Formula]
C25H19F2N5O2 | [MDL Number]
MFCD32263051 | [MOL File]
2471967-92-5.mol | [Molecular Weight]
459.45 |
| Chemical Properties | Back Directory | [density ]
1.397±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO: 1mg/mL, clear | [form ]
Solid | [pka]
12.52±0.40(Predicted) | [color ]
White to off-white | [Optical Rotation]
[α]/D 165 to 195°, c =1 in chloroform-d | [InChIKey]
VKQBTIMLSDGNLG-QHCPKHFHSA-N | [SMILES]
O=C(N1[C@@H](C2=CC=C(F)C=C2)C3=C(N=CC=C3)CC1)NC4=CN=C(OC5=CC=C(F)C=C5)N=C4 |
| Hazard Information | Back Directory | [Uses]
BAY-899 is an orally active and selective luteinizing hormone receptor (LH-R) antagonist with IC50s of 185 nM and 46nM for hLH (human LH) and rLH (rat LH), respectively. BAY-899 can reduce sex hormone levels[1]. | [Biological Activity]
BAY-899 is an orally availablepotent and selective antagonist of the human luteinizing hormone receptor (hLH-R) th at reduces sex hormone levels in several animal models. BAY-899 likely binds to a putative rhodopsin-like binding cavity located within the 7-transmembrane region of the hLH-receptor. | [in vivo]
BAY-899 (oral; 12.5 mg/kg/day; for 8 days) shows an efficiency to reduce serum estradiol levels in intact female rats[1].
BAY-899 (iv of 0.5 mg/kg or po of 2 mg/kg) has a t1/2 of 11 hours and 12 hours for iv and po. And the Cmax is 0.97 kg/L and 0.24 kg/L for iv and po[1].
| Animal Model: | Intact female rats[1] | | Dosage: | 12.5 mg/kg | | Administration: | Oral; for 8 days | | Result: | Showed an efficiency to reduce serum estradiol levels.
|
| Animal Model: | Female and male Wistar rats[1] | | Dosage: | 0.5 mg/kg of iv or 2 mg/kg of po | | Administration: | Iv or po | | Result: | Has t1/2s of 11 hours and 12 hours for iv and po. And the Cmaxs are 0.97 kg/L and 0.24 kg/L for iv and po.
|
| [References]
[1] Wortmann L, et al. Discovery of BAY-298 and BAY-899: Tetrahydro-1,6-naphthyridine-Based, Potent and Selective Antagonists of the Luteinizing Hormone Receptor Which Reduce Sex Hormone Levels In Vivo. J Med Chem. 2019 Oct 31. DOI:10.1021/acs.jmedchem.9b01382 |
|
| Company Name: |
Merck KGaA
|
| Tel: |
21-20338288 |
| Website: |
www.sigmaaldrich.cn |
| Company Name: |
MedChemExpress
|
| Tel: |
021-58955995 |
| Website: |
www.medchemexpress.com |
|